Ken Griffin Genetron Holdings LTD Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.4 $84,663 - $158,743	-66,143 Reduced 51.08%	63,341 $108,000
Q1 2022 May 16, 2022	SELL	$2.19 - $6.09 $26,855 - $74,681	-12,263 Reduced 8.65%	129,484 $284,000
Q4 2021 Feb 14, 2022	BUY	$5.81 - $14.39 $823,550 - $2.04 Million	141,747 New	141,747 $864,000
Q3 2021 Nov 15, 2021	SELL	$11.55 - $20.3 $176,102 - $309,514	-15,247 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.9 - $23.29 $476,408 - $619,863	-26,615 Reduced 63.58%	15,247 $307,000
Q1 2021 May 17, 2021	SELL	$13.71 - $30.64 $43,789 - $97,864	-3,194 Reduced 7.09%	41,862 $898,000
Q4 2020 Feb 16, 2021	BUY	$9.31 - $14.0 $269,729 - $405,608	28,972 Added 180.13%	45,056 $631,000
Q3 2020 Nov 16, 2020	SELL	$9.1 - $15.81 $1.62 Million - $2.82 Million	-178,065 Reduced 91.72%	16,084 $192,000
Q2 2020 Aug 14, 2020	BUY	$11.29 - $16.0 $2.19 Million - $3.11 Million	194,149 New	194,149 $2.34 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.